Rob Ree - Profile and Investment Details

Investor Profile

Rob Ree is a Venture Capital, Micro VC, Investor based in Amsterdam, North Holland, The Netherlands with a diverse investment portfolio that includes companies such as Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics, NorthSea Therapeutics, VarmX, Citryll, Synaffix BV, Ventinova Medical, Mellon Medical B.V., Escalier Biosciences, Azafaros, Mucosis, FlexGen, Medtronic, AcertaPharma, Medisse, Mellon Medical, Dezima Pharma, Crucell, arGEN-X, . Over time, Rob Ree has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Rob Ree is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Talent Management, Research and Development, Wellness, Enterprise Software, Healthcare Innovation, Public Policy, Life Science, Medical Technologies, Health Care Policy, Manufacturing, Biotechnology, Consumer Health, Electronic Health Records (EHR), Health and Hospital Services, Neuroscience, Research, Consumer Software, Personalized Medicine, Digital Health, Medical, Big Data, Information Technology, B2B, Therapeutics, Molecular Diagnostics, Pharmaceuticals may find it worthwhile to explore potential connections with Rob Ree, as their portfolio suggests a familiarity and interest in this area.

Understanding Rob Ree’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.